1. Home
  2. NNBR vs ABEO Comparison

NNBR vs ABEO Comparison

Compare NNBR & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NN Inc.

NNBR

NN Inc.

N/A

Current Price

$2.82

Market Cap

319.7M

Sector

Industrials

ML Signal

N/A

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

N/A

Current Price

$2.74

Market Cap

282.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NNBR
ABEO
Founded
1980
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
319.7M
282.5M
IPO Year
1996
2005

Fundamental Metrics

Financial Performance
Metric
NNBR
ABEO
Price
$2.82
$2.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$7.00
★ $15.56
AVG Volume (30 Days)
★ 2.2M
2.1M
Earning Date
10-28-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
3.60
★ 165.16
EPS
★ N/A
N/A
Revenue
★ $770,657,000.00
$2,998,000.00
Revenue This Year
$16.85
$675.42
Revenue Next Year
$7.19
$126.99
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 258.18
52 Week Low
$1.10
$2.09
52 Week High
$4.65
$7.65

Technical Indicators

Market Signals
Indicator
NNBR
ABEO
Relative Strength Index (RSI) 38.54 30.01
Support Level $2.74 N/A
Resistance Level $3.06 $5.77
Average True Range (ATR) 0.25 0.32
MACD -0.04 -0.07
Stochastic Oscillator 13.16 25.61

Price Performance

Historical Comparison
NNBR
ABEO

About NNBR NN Inc.

NN Inc is a diversified industrial company that combines engineering and production capabilities with materials science expertise to design and manufacture high-precision components and solutions. The company operates through two segments: Mobile Solutions, which generates maximum revenue and focuses on the automotive, general industrial, and medical end markets, manufacturing tight-tolerance components used in battery electric, hybrid electric, and internal combustion engine vehicles, braking, transmissions, fuel systems, HVAC, and diesel systems; and Power Solutions, which focuses on the electrical, general industrial, automotive, medical, and aerospace and defense end markets and manufactures high-precision metal components, assemblies, contact assemblies, and precision stampings.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Share on Social Networks: